Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-13 Sale | 2024-03-13 4:36 pm | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 8,891 | $162.16 | $1,441,765 | 15,043 (Direct) | View |
| 2024-02-16 Sale | 2024-03-06 3:42 pm | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 3,725 | $25.81 | $96,142 | 4,103,430 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-04-10 5:05 pm | N/A N/A | Contineum Therapeutics Inc. | CTNM | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 0 | $0 | 1,979,173 (Indirect) | View |
| 2024-03-05 Option Award | 2024-03-07 4:58 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director | 753 | $159.8 | 1,245 (Direct) | View |
| 2024-03-05 Option Award | 2024-03-07 4:58 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 235 | $159.8 | 8,788 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-06 3:42 pm | N/A 2024-11-18 | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 3,855 | $0 | 4,103,430 (Indirect) | View |
| 2024-02-16 Exercise | 2024-03-06 3:42 pm | N/A N/A | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 607,725 | $0.158 | 4,103,430 (Indirect) | View |
| 2024-02-29 Exercise | 2024-03-06 3:42 pm | N/A N/A | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 79 | $5.141 | 4,103,430 (Indirect) | View |
| 2024-02-29 Exercise | 2024-03-06 3:42 pm | N/A N/A | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 2,940 | $0.237 | 4,103,430 (Indirect) | View |
| 2024-02-29 Exercise | 2024-03-06 3:42 pm | N/A N/A | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 252 | $3.955 | 4,103,430 (Indirect) | View |
| 2024-02-29 Exercise | 2024-03-06 3:42 pm | N/A N/A | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 584 | $1.186 | 4,103,430 (Indirect) | View |
| 2024-02-16 Exercise | 2024-03-06 3:42 pm | N/A N/A | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 607,225 | $0 | 4,103,430 (Indirect) | View |
| 2024-02-15 Option Award | 2024-02-20 5:58 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 81,763 | $0 | 81,763 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:56 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 31,094 | $0 | 31,094 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:56 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 52,743 | $0 | 52,743 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:55 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Hait William EVP, Chief EI and Med Officer | 36,851 | $0 | 36,851 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:55 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 25,220 | $0 | 25,220 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:55 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 69,211 | $0 | 69,211 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:55 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 101,110 | $0 | 101,110 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:55 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 49,289 | $0 | 49,289 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:54 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 188,862 | $0 | 188,862 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:54 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer | 43,070 | $0 | 43,070 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:54 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 25,220 | $0 | 25,220 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:54 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 9,191 | $0 | 9,191 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 651 | $0 | 83,913 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 333 | $157.85 | 83,913 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 1,780 | $0 | 74,496 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 773 | $157.85 | 74,496 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 1,302 | $0 | 157,455 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 666 | $157.85 | 157,455 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 447 | $0 | 15,464 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 195 | $157.85 | 15,464 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 499 | $0 | 14,784 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 250 | $157.85 | 14,784 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer | 925 | $0 | 113,924 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer | 474 | $157.85 | 113,924 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Hait William See Remarks | 834 | $0 | 40,313 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Hait William See Remarks | 427 | $157.85 | 40,313 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 3,470 | $0 | 371,124 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 1,507 | $157.85 | 371,124 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 651 | $0 | 9,642 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 236 | $157.85 | 9,642 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 408 | $0 | 24,750 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 209 | $157.85 | 24,750 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 313 | $0 | 20,328 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 86 | $157.85 | 20,328 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 6:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 790 | $0 | 23,735 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-14 6:36 pm | 2024-02-08 N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 4,701 | $0 | 23,735 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 6:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 2,136 | $157.4 | 23,735 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-14 6:36 pm | 2024-02-08 N/A | JOHNSON & JOHNSON | JNJ | Hait William See Remarks | 8,932 | $0 | 38,240 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 6:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Hait William See Remarks | 4,076 | $157.4 | 38,240 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-14 6:36 pm | 2024-02-08 N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 25,835 | $0 | 69,931 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 6:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 10,816 | $157.4 | 69,931 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-14 6:36 pm | 2024-02-08 N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 2,859 | $0 | 7,925 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 6:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 1,034 | $157.4 | 7,925 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-14 6:36 pm | 2024-02-08 N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 26,202 | $0 | 154,215 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 6:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 13,403 | $157.4 | 154,215 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-14 6:36 pm | 2024-02-08 N/A | JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer | 14,960 | $0 | 111,625 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 6:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer | 7,019 | $157.4 | 111,625 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-14 6:36 pm | 2024-02-08 N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 5,456 | $0 | 14,318 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 6:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 1,695 | $157.4 | 14,318 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-14 6:36 pm | 2024-02-08 N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 36,618 | $0 | 362,222 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 6:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 15,900 | $157.4 | 362,222 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-14 6:36 pm | 2024-02-08 N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 5,736 | $0 | 13,537 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 6:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 2,887 | $157.4 | 13,537 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-14 6:36 pm | 2024-02-08 N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 1,912 | $0 | 19,477 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 6:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 523 | $157.4 | 19,477 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-14 6:36 pm | 2024-02-08 N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 13,813 | $0 | 82,293 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 6:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 7,066 | $157.4 | 82,293 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 5:18 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 27,333 | $156.76 | 75,546 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-13 5:18 pm | 2017-02-11 2024-02-09 | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 35,638 | $90.44 | 75,546 (Direct) | View |